Featured Report

Medicine Use and Spending in the U.S.: A Review of 2018 and Outlook to 2023

This report provides objective measures of medicine use and its costs to the U.S. healthcare system and patients, employers, health plans, intermediaries and state and federal government agencies. The report specifically focuses on the volume of medicine use – with a special attention on opioids – drivers of change in the use of medicines, overall "net spending," out-of-pocket costs to patients, and an outlook through 2023 for the pharmaceuticals market. It additionally examines the key dynamics around new product launches, patent expiries and the introduction of generics and biosimilars.